William Dai
InvestorManaging Partner at ShangBay Capital LLC · Board director at Apostle · Board director at NeuroVasc
Palo Alto, California
Writes $100K – $5M checks · typically $1.5M
About
William Dai is the Founding Managing Partner of ShangBay Capital, an early-stage medtech-focused VC firm he started in 2015. Before founding the firm, he spent over 20 years in corporate finance, M&A, and capital markets in Asia and the U.S., serving as CFO of ShangPharma, Nepstar Corporation, Microport Scientific Corporation, and Boston Scientific China, and beginning his career as a Finance Manager at Ford Motor Company. He holds an MBA with a finance emphasis from Michigan State University.
Contact· self-published, not guessed
Invests in
Medical Devices
Board director at Apostle
Intro paths
→
In turn, William can intro founders to Apostle's investors below.
Apostle's investors · 2
-2.png)
Co-founders at Apostle
DG
Dongliang GeExecutive Officer, Director
Board director at NeuroVasc
Intro paths
→
In turn, William can intro founders to NeuroVasc's investors below.
NeuroVasc's investors · 2
Experience
- Luminopia Inc.Board Membercurrent2022 — presentBoston, Massachusetts, United States
- ShangBay CapitalFounding Managing Partnercurrent2015 — presentPalo Alto, California, United States
- ShangBay CapitalFounding Managing Partnercurrent2015 — presentPalo Alto, California, United States
- YorLabsBoard Membercurrent2021 — presentOregon, United States
- Laplace InterventionalBoard Membercurrent2021 — presentMinneapolis, Minnesota, United States
- SetPoint MedicalBoard Observercurrent2022 — presentSanta Clarita, California, United States
- SetPoint MedicalBoard Member2020 — 2022United States
- Aqua MedicalBoard Membercurrent2020 — presentSanta Ana, California, United States
- FemDx MedicalBoard Membercurrent2020 — presentSanta Clara County, California, United States
- Huma.AIBoard Membercurrent2019 — presentLos Altos, California
- Meditrina IncBoard Membercurrent2019 — presentSan Jose, California
- Corinth MedicalBoard Membercurrent2019 — presentCupertino, California
- Apostle, IncBoard Membercurrent2017 — presentSanta Clara, California
- Emboline, Inc.Board Member2018 — 2021
- NeuroVasc Technologies Inc.Board Member2015 — 2019Laguna Hills, California
- ARRINEX, INC.Board Member2016 — 2019Redwood City, California
- Ceribell, IncBoard Member2015 — 2017Mountain View, California
- ShangPharma Corporation (NYSE: SHP)CFO2011 — 2014
- NepstarCFO2009 — 2010
- MicroPort Scientific (HK: 00853)CFO2006 — 2008
- Purdue Pharma (Mundipharma)Chief Representative of Shanghai Rep Office2005 — 2006Shanghai, China
- Boston ScientificDirector, Strategy & Business Development2002 — 2005Shanghai, China
- Boston ScientificCFO, China Operations1999 — 2002Shanghai, China
- Case CorporationFinance Director1996 — 1999Racine, Wisconsin
- Ford Motor CompanySenior Financial Analyst1993 — 1996Dearborn, Michigan
Skills & more
Financial Modeling74Venture Capital58Mergers10Corporate Finance33Corporate Development25International Business9Financial Reporting6Sarbanes-Oxley Act5Mergers & Acquisitions48Private Equity16Valuation18Acquisition Integration16
+10 more
RestructuringInvestor RelationsM&A experienceDue DiligenceBusiness StrategyFinanceBusiness DevelopmentBusiness PlanningStrategyStrategic PlanningFrom William's professional profile.
Investments
Board seats
ApostleAqua MedicalArrinexCorinth MedtechEarly Bird MedicalEmbolineFemDxLaplace InterventionalLuminopiaMeditrinaNeuroVascSetPoint MedicalYorlabs
Per the firm's website.
Colleagues at ShangBay Capital LLC
Andrew Chen
Senior Associate at ShangBay Capital LLC
Andy Weimin Dai
Senior Advisor at ShangBay Capital LLC
Chaucer Shen
Managing Partner at ShangBay Capital LLC
Cindy Costello
Director of Finance & Administration at ShangBay Capital LLC
Dr. Malcolm G. Munro
Senior Medical Advisor at ShangBay Capital LLC
Erik T. Engelson
Venture Partner at ShangBay Capital LLC
Ethan Kau
Analyst at ShangBay Capital LLC
Mel Dong
Senior Advisor at ShangBay Capital LLC
Frequently asked questions
- Who is William Dai?
- William Dai is the Founding Managing Partner of ShangBay Capital, an early-stage medtech-focused VC firm he started in 2015. Before founding the firm, he spent over 20 years in corporate finance, M&A, and capital markets in Asia and the U.S., serving as CFO of ShangPharma, Nepstar Corporation, Microport Scientific Corporation, and Boston Scientific China, and beginning his career as a Finance Manager at Ford Motor Company. He holds an MBA with a finance emphasis from Michigan State University.
- Where does William Dai work?
- William Dai is Managing Partner at ShangBay Capital LLC and Board director at Apostle and Board director at NeuroVasc.
- What does William Dai invest in?
- William Dai invests in Medical Devices.
- What check size does William Dai write?
- William Dai typically writes checks of $100K – $5M.
- What boards does William Dai sit on?
- William Dai holds tracked board seats at Apostle, Aqua Medical, Arrinex, Corinth Medtech, Early Bird Medical, Emboline, FemDx, Laplace Interventional, Luminopia, Meditrina.
- Where did William Dai go to school?
- William Dai studied at Michigan State University - The Eli Broad Graduate School of Management (MBA, Finance).
Shared employers
Also worked at SetPoint Medical3
Also worked at Huma.AI2
Also worked at Boston Scientific46
Ben CoughlanInvestor at Moonfire VenturesRobin BorgInvestor at TRANSFORMATION CAPITALTroy BurtonHead of Product at Red Cell IncubationRache SimmonsBreast Cancer Surgeon at FemHealth VenturesChris ShanahanPrincipal at DFJDavid ThompsonGeneral Partner at 415 Capital
+ 40 more
